{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:58:51Z","timestamp":1790161131538,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["S2020SFYLJS0327"],"award-info":[{"award-number":["S2020SFYLJS0327"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2018SK52508"],"award-info":[{"award-number":["2018SK52508"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81,771,546"],"award-info":[{"award-number":["81,771,546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.yexcr.2022.113388","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T02:54:33Z","timestamp":1665802473000},"page":"113388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value"],"prefix":"10.1016","volume":"421","author":[{"given":"Chunying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suye","family":"Suye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-1159","authenticated-orcid":false,"given":"Chun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2022.113388_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2022.113388_bib2","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2022.113388_bib3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2022.113388_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexcr.2022.113388_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: pooled data about prognosis","volume":"155","author":"Raffone","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2021.02.015","article-title":"Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer","volume":"161","author":"Da Cruz Paula","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211035959","article-title":"The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer","volume":"13","author":"Jamieson","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2018.05.015","article-title":"Endometrial cancer: molecular markers and management of advanced stage disease","volume":"150","author":"Arend","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/ijgc-2020-002256","article-title":"Understanding the most aggressive endometrial cancers in the era of molecular classification","volume":"31","author":"Jamieson","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.yexcr.2022.113388_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2022.113388_bib12","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/annonc\/mdt290","article-title":"Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer","volume":"24","author":"Fagerholm","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib13","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2019.10046","article-title":"Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer","author":"Feng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2022.113388_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030042","article-title":"BRCAness profile of sporadic ovarian cancer predicts disease recurrence","volume":"7","author":"Wysham","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2022.113388_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-14-246","article-title":"Gene expression profiling reveals activation of the FA\/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure","volume":"14","author":"Balacescu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2022.113388_bib16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3892\/or.2017.5904","article-title":"FTO expression is associated with the occurrence of gastric cancer and prognosis","volume":"38","author":"Xu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2022.113388_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.yexcr.2022.113388_bib18","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1158\/1078-0432.CCR-10-0292","article-title":"DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer","volume":"16","author":"Alexander","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2022.113388_bib19","first-page":"492","volume":"2011","author":"Soulier","year":"2011","journal-title":"Fanconi Anemia, Hematol."},{"key":"10.1016\/j.yexcr.2022.113388_bib20","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1471-2091-8-S1-S10","article-title":"The Fanconi anemia pathway and ubiquitin","volume":"8","author":"Jacquemont","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.yexcr.2022.113388_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.07.090","article-title":"Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment","volume":"143","author":"Talhouk","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/carcin\/bgl062","article-title":"FANCD2 associated with sporadic breast cancer risk","volume":"27","author":"Barroso","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2022.113388_bib23","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/cncr.30802","article-title":"Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50","volume":"123","author":"Chandrasekharappa","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2022.113388_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4161\/cbt.3.6.844","article-title":"Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot","volume":"3","author":"van der Heijden","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2022.113388_bib25","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/1878-0261.13072","article-title":"FANCD2 limits acetaldehyde\u2010induced genomic instability during DNA replication in esophageal keratinocytes","volume":"15","author":"Peake","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib26","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.3390\/cancers12092545","article-title":"FANCD2 confers a malignant phenotype in esophageal squamous cell carcinoma by regulating cell cycle progression","volume":"12","author":"Lei","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2022.113388_bib27","unstructured":"M.W. Ho, Loss of FANCD2 and Related Proteins May Predict Malignant Transformation in Oral Epithelial Dysplasia, (n.d.) 22."},{"key":"10.1016\/j.yexcr.2022.113388_bib28","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2353\/ajpath.2010.090779","article-title":"Significance of the fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer","volume":"176","author":"Rudland","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113388_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2014.02.002","article-title":"Expression of DNA repair proteins in endometrial cancer predicts disease outcome","volume":"132","author":"Mhawech-Fauceglia","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113388_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2022.113388_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/path.1450","article-title":"FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia: FANCD2 expression in tissues predisposed to cancer development in FA patients","volume":"201","author":"H\u00f6lzel","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2022.113388_bib32","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.4161\/cc.9.12.11900","article-title":"A novel role for fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells","volume":"9","author":"Song","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2022.113388_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2016.03.002","article-title":"Targeting CDK4\/6 in patients with cancer","volume":"45","author":"Hamilton","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.yexcr.2022.113388_bib34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","article-title":"Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway","volume":"5","author":"Chirnomas","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2022.113388_bib35","first-page":"305","article-title":"Gamma-H2AX - a novel biomarker for DNA double-strand breaks","volume":"22","author":"Kuo","year":"2008","journal-title":"Vivo Athens Greece"},{"key":"10.1016\/j.yexcr.2022.113388_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14737159.2022.2020102","article-title":"RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?","volume":"22","author":"van Wijk","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.yexcr.2022.113388_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12929-015-0185-4","article-title":"RNA interferences targeting the Fanconi anemia\/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells","volume":"22","author":"Dai","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.yexcr.2022.113388_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.570084","article-title":"DNA repair syndromes and cancer: insights into genetics and phenotype patterns","volume":"8","author":"Sharma","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.yexcr.2022.113388_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1101\/gr.165985.113","article-title":"Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival","volume":"24","author":"Brown","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.yexcr.2022.113388_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-18-1443","article-title":"Frequent homologous recombination deficiency in high-grade endometrial carcinomas","volume":"25","author":"de Jonge","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2022.113388_bib41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.24039","article-title":"A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway","volume":"124","author":"Landais","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2022.113388_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1541-7786.MCR-11-0497","article-title":"Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents","volume":"10","author":"Kee","year":"2012","journal-title":"Mol. Cancer Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482722003810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482722003810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:53:26Z","timestamp":1777420406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482722003810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0014482722003810"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2022.113388","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2022.113388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113388"}}